Follicular thyroid cancer
ICD-10 C73 · ICD-11 2D10.0

Follicular Thyroid Cancer After Thyroidectomy: What to Do When an Excellent Response Is Not Achieved

After initial surgical treatment for follicular thyroid cancer, achieving an excellent response is the primary goal. When that threshold is not met, a structured next-line protocol determines the appropriate course of action.

Previous Treatment & Failure Condition

The standard initial approach is total thyroidectomy — or, for selected low-risk tumours, lobectomy alone. An excellent response is defined as negative imaging, undetectable anti-thyroglobulin antibodies, and a basal serum thyroglobulin below the established threshold. When these criteria are not reached following surgery, this next-line protocol applies.

Next-Line Approach (Partial Overview)

The subsequent strategy centres on radioactive iodine therapy, delivered after appropriate thyroid-stimulating hormone stimulation. The full protocol specifies the method of TSH stimulation, how patient risk profile shapes the approach, and all further details — none of which are shown here.

Instant Access to Structured Evidence-Based Regimens

References

  1. As shown in Figure 2, practice guidelines unanimously recommend treatment with high RAI activities for patients with high risk of recurrence [IV, A].
  2. Low activities are usually given for remnant ablation; high activities are used for treatment purposes.
  3. RAI therapy may be considered in intermediate-risk patients (rhTSH administration or levothyroxine withdrawal) [IV, B]; decisions on RAI dosage and TSH stimulation modalities are based on case features.
  4. To optimise isotope uptake, RAI should be given after thyroid-stimulating hormone (TSH) stimulation, which can be achieved by withdrawing levothyroxine for 4–5 weeks, ideally until serum TSH levels reach 30 mIU/ml.
View source ↗